Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gamolenic acid 37mg / Vitamin E 10unit capsules
1305010I0AAAPAP
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 67.5mg/5ml oral solution
1305010I0AAAMAM
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 74mg / Vitamin E 10unit capsules
1305010I0AAAQAQ
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 90mg / Vitamin E 10unit capsules
091200000AAEPEP
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Gamolenic acid 90mg / Vitamin E 15unit capsules
1305010I0AAAIAI
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 95mg / Vitamin E 15unit capsules
1305010I0AAANAN
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamophase 40mg capsules
1305010I0BGAAAA
|
Gamophase | Gamolenic acid | Skin | No data available |
|
Gamten 10g/100ml solution for infusion bottles
1405010A0CJAABL
|
Gamten | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Gamten 20g/200ml solution for infusion bottles
1405010A0CJABBY
|
Gamten | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Gamten 5g/50ml solution for infusion bottles
1405010A0CJACBK
|
Gamten | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Gamunex 10% 10g/100ml solution for infusion vials
1405010A0BYABBQ
|
Gamunex | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Gamunex 10% 1g/10ml solution for infusion vials
1405010A0BYADBU
|
Gamunex | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Gamunex 10% 20g/200ml solution for infusion vials
1405010A0BYACBR
|
Gamunex | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Gamunex 10% 5g/50ml solution for infusion vials
1405010A0BYAABP
|
Gamunex | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Ganciclovir 250mg capsules
0503022D0AAACAC
|
Ganciclovir | Ganciclovir | Infections | No data available |
|
Ganciclovir 500mg capsules
0503022D0AAADAD
|
Ganciclovir | Ganciclovir | Infections | No data available |
|
Ganciclovir 500mg powder for solution for infusion vials
0503022D0AAAAAA
|
Ganciclovir | Ganciclovir | Infections | No data available |
|
Ganda 1 + 0.2 eye drops
1106000S0BCAAAE
|
Ganda | Guanethidine monosulfate | Eye | No data available |
|
Ganda 3 + 0.5 eye drops
1106000S0BCABAF
|
Ganda | Guanethidine monosulfate | Eye | No data available |
|
Garamycin 0.3% eye/ear drops
1103010G0BCAAAF
|
Garamycin (Ear/Eye) | Gentamicin sulfate | Eye | No data available |
|
Gardenal Sodium 200mg/1ml solution for injection ampoules
0408010P0BBAAAA
|
Gardenal sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Garlic capsules
091200000AABKBK
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Gastrobid Continus 15mg tablets
0406000P0BIAAAH
|
Gastrobid Continus | Metoclopramide hydrochloride | Central Nervous System | No data available |
|
Gastrocote chewable tablets
0101021B0BCAAAC
|
Gastrocote | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Gastroflux 10mg tablets
0406000P0BLAAAE
|
Gastroflux | Metoclopramide hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.